Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Novel approaches to allogeneic stem cell therapy.

V Bhatia1, D L Porter

  • 1Bone Marrow and Stem Cell Transplant Program, Hematology-Oncology Division, Department of Medicine, University of Pennsylvania Medical Center, Philadelphia, PA, USA.

Expert Opinion on Biological Therapy
|December 1, 2001
PubMed
Summary

Non-myeloablative allogeneic cell therapy (ACT) leverages the graft-versus-tumor (GVT) effect for hematologic diseases. This approach reduces conditioning toxicity, expanding eligibility for stem cell transplantation (SCT).

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Drone-based sputum transport for TB diagnosis in remote communities.

IJTLD open·2026
Same author

Morbidity profile of the patients attending Mobile Medical Unit camps in Telangana: A record-based study.

Archives of Razi Institute·2024
Same author

More is needed to end TB: commentary on the United Nations High-Level Meeting on TB.

IJTLD open·2024
Same author

Comparative Analysis of Stereotactic Radiation Therapy and Conventional Radiation Therapy in Cancer Pain Control: A Systematic Review and Meta-Analysis.

Clinical oncology (Royal College of Radiologists (Great Britain))·2024
Same author

Bendamustine is safe and effective for lymphodepletion before tisagenlecleucel in patients with refractory or relapsed large B-cell lymphomas.

Annals of oncology : official journal of the European Society for Medical Oncology·2022
Same author

Dermoscopy as an Auxiliary Tool in the Assessment of Malassezia Folliculitis: An Observational Study.

Actas dermo-sifiliograficas·2022

Area of Science:

  • Immunology
  • Oncology
  • Hematology

Background:

  • Allogeneic stem cell transplantation (SCT) traditionally uses myeloablative conditioning, limiting its use to younger, healthier patients due to high morbidity and mortality.
  • The graft-versus-tumor (GVT) effect, mediated by donor immune cells, is crucial for SCT success and can be exploited independently of conditioning intensity.
  • Donor leukocyte infusions (DLI) demonstrate the GVT effect, leading to durable remissions in relapsed leukemia post-SCT.

Purpose of the Study:

  • To explore a novel allogeneic cell therapy (ACT) approach using non-myeloablative conditioning regimens.
  • To enable engraftment of allogeneic stem cells and lymphocytes, harnessing their GVT activity with reduced conditioning toxicity.
  • To expand the applicability of allogeneic transplantation to patients typically ineligible for conventional SCT.

Related Experiment Videos

Main Methods:

  • Utilizing non-myeloablative, immunosuppressive conditioning regimens to facilitate donor cell engraftment.
  • Employing allogeneic cell therapy (ACT) to leverage the graft-versus-tumor (GVT) effect.
  • Investigating the clinical benefit of reduced toxicity conditioning in allogeneic SCT.

Main Results:

  • Impressive response rates observed with non-myeloablative conditioning and ACT strategies.
  • Graft-versus-host disease (GVHD) and other complications remain a concern, requiring further management.
  • Current trials involve heterogeneous patient groups and various conditioning regimens, with unsettled issues regarding optimal targets and regimens.

Conclusions:

  • Non-myeloablative conditioning and ACT represent a potential new paradigm for allogeneic cell transplantation.
  • This approach aims to maximize the immunologic GVT effect while minimizing treatment toxicity.
  • Further research is needed to define optimal conditioning regimens, tumor targets, and assess response durability.